Heterobicyclic mGluR Agonists
J ournal of Medicinal Chemistry, 1999, Vol. 42, No. 6 1039
(9) Ito, I.; Kohda, A.; Tanabe, S.; Hirose, E.; Hayashi, M.; Mitsunaga,
S.; Sugiyama, H. 3,5-Dihydroxyphenylglycine: A potent agonist
of metabotropic glutamate receptors. NeuroReport 1992, 3,
1013-1016.
(10) Birse, E. F.; Eaton, S. A.; J ane, D. E.; J ones, P. L. St. J .; Porter,
R. H. P.; Pook, P. C.-K.; Sunter, D. C.; Udvarhelyi, P. M.;
Wharton, B.; Roberts, P. J .; Salt, T. E.; Watkins, J . C. Phenyl-
glycine derivatives as new pharmacological tools for investigat-
ing the role of metabotropic glutamate receptors in the central
nervous system. Neuroscience 1993, 52, 481-488.
(11) Schoepp, D. D.; Goldsworthy, J .; J ohnson, B. G.; Salhoff, C. R.;
Baker, S. R. 3,5-Dihydroxyphenylglycine is a highly selective
agonist for phosphoinositide-linked metabotropic glutamate
receptors in the rat hippocampus. J . Neurochem. 1994, 63, 769-
772.
The reaction of diazoalkanes with thiophen. J . Chem. Soc.,
Perkin Trans. 1. 1979, 2624-2628.
(25) Brown, H. C.; Vara Prasad, J . V. N.; Zee, S.-H. Hydroboration.
71. Hydroboration of representative heterocyclic olefins with
borane-methyl sulfide, 9-borabicyclo[3.3.1]nonane, dicyclohexyl-
borane, and disiamylborane. Synthesis of heterocyclic alcohols.
J . Org. Chem. 1985, 50, 1582-1589.
(26) Minor amounts (10-20%) of the undesired C4-5′-spirohydan-
toins resulting from cyanide approach from the more hindered
(concave) face of these molecules were also observed in the crude
reaction mixtures. The relative stereochemistry about the spi-
rocyclic ring juncture of the desired rac-C4-5′-spirohydantoins
14 and 20 was determined by the observation of diagnostic NOEs
between the hydantoin 1′-NH proton, H3R, and H6 (below).
(12) Doherty, A. J .; Palmer, M. J .; Henley, J . M.; Collingridge, G. L.;
J ane, D. E. (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) ac-
tivates mGlu5, but not mGlu1, receptors expressed in CHO cells
and potentiates NMDA responses in the hippocampus. Neuro-
pharmacology 1997, 36, 265-267.
(13) Schoepp, D. D.; J ohnson, B. G.; Monn, J . A. Inhibition of cyclic
AMP formation by a selective metabotropic glutamate receptor
agonist. J . Neurochem. 1992, 58, 1184-1186.
(14) Schoepp, D. D.; J ohnson, B. G.; Salhoff, C. R.; Valli, M. J .; Desai,
M. A.; Burnett, J . P.; Mayne, N. G.; Monn, J . A. Selective
inhibition of forskolin-stimulated cyclic AMP formation in rat
hippocampus by a novel mGluR agonist, 2R,4R-4-amino-pyrrol-
idine-2,4-dicarboxylate. Neuropharmacology 1995, 34, 843-850.
(15) Monn, J . A.; Valli, M. J .; J ohnson, B. G.; Salhoff, C. R.; Wright,
R. A.; Howe, T.; Bond, A.; Lodge, D.; Griffey, K.; Tizzano, J . P.;
Schoepp, D. D. Synthesis of the four isomers of 4-aminopyrrol-
idine-2,4-dicarboxylate (APDC): identification of a potent, highly
selective, and systemically active agonist for metabotropic
glutamate receptors negatively coupled to adenylate cyclase. J .
Med. Chem. 1996, 39, 2990-3000.
(16) Schoepp, D. D.; J ohnson, B. G.; Wright, R. A.; Salhoff, C. R.;
Mayne, N. G.; Wu, S.; Cockerham, S. L.; Burnett, J . P.; Belagaje,
R.; Bleakman, D.; Monn, J . A. LY354740 is a potent and highly
selective group II metabotropic glutamate receptor agonist in
cells expressing human glutamate receptors. Neuropharmacol-
ogy 1997, 36, 1-11.
(17) Monn, J . A.; Valli, M. J .; Massey, S. M.; Wright, R. A.; Salhoff,
C. R.; J ohnson, B. G.; Howe, T.; Alt, C. A.; Rhodes, G. A.; Robey,
R. L.; Griffey, K. R.; Tizzano, J . P.; Kallman, M. J .; Helton, D.
R.; Schoepp, D. D. Design, synthesis and pharmacological
characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicar-
boxylic Acid (LY354740): a potent, selective and orally active
group 2 metabotropic glutamate receptor agonist possessing
anticonvulsant and anxiolytic properties. J . Med. Chem. 1997,
40, 528-537.
(18) Kristensen, P.; Suzdak, P. D.; Thomsen, C. Expression pattern
and pharmacology of the rat type IV metabotropic glutamate
receptor. Neurosci. Lett. 1993, 155, 159-162.
(19) Tanabe, Y.; Nomura, A.; Masu, M.; Shigemoto, R.; Mizuno, N.;
Nakanishi, S. Signal transduction, pharmacological properties,
and expression patterns of two rat metabotropic glutamate
receptors, mGluR3 and mGluR4. J . Neurosci. 1993, 13, 1372-
1378.
(20) Nakajima, Y.; Iwakabe, H.; Akazawa, C.; Nawa, H.; Shigemoto,
R.; Mizuno, N.; Nakanishi, S. Molecular characterization of a
novel retinal metabotropic glutamate receptor mGluR6 with a
high agonist selectivity for L-2-amino-4-phosphonobutyrate. J .
Biol. Chem. 1993, 268, 11868-11873.
(21) Okamoto, N.; Hori, S.; Akazawa, C.; Hayashi, Y.; Shigemoto, R.;
Mizuno, N.; Nakanishi, S. Molecular characterization of a new
metabotropic glutamate receptor mGluR7 coupled to inhibitory
cyclic AMP signal transduction. J . Biol. Chem. 1994, 269, 1231-
1236.
(27) The enantiomeric purities of (-)-15, (+)-15, (-)-21, and (+)-21
were determined by chiral HPLC (see General Methods, Ex-
perimental Section, for details). Under these conditions, (-)-15
and (+)-15 exhibited elution times of 9.5 and 8.3 min, respec-
tively. (-)-21 and (+)-21 exhibited elution times of 10.5 and 9.4
min, respectively.
(28) The X-ray structure and coordinates for (-)-9 have been filed
with the Cambridge Crystallographic Database. Crystallographic
data for (-)-9 is available as Supporting Information.
(29) Sills, M. A.; Williams, M.; Wilusz, E. J .; Hurt, S. D.; Brundish,
D. E.; Angst C.; Pozza M.; Fagg, G. [3H]CGP 39653: a new
N-methyl-D-aspartate antagonist radioligand with low nano-
molar affinity in rat brain. Eur. J . Pharmacol. 1991, 192, 19-
24.
(30) Nielsen, E. O.; Madsen, U.; Schaumburg, K.; Brehm, L.; Krogs-
gaard-Larsen, P. Studies on receptor-active conformations of
excitatory amino acid agonists and antagonists. Eur. J . Med.
Chem. - Chim. Ther. 1986, 21, 433-437.
(31) Simon, J . R.; Contrera, J . F.; Kuhar, M. J . Binding of [3H]kainic
Acid, an analogue of L-glutamate, to brain membranes. J .
Neurochem. 1976, 26, 141-147.
(32) Ornstein, P. L.; Arnold, M. B.; Bleisch, T. J .; Wright, R. A.;
Wheeler, W. J .; Schoepp, D. D. [3H]LY341495, A highly potent,
selective and novel radioligand for labeling group II metabotropic
glutamate receptors. Bioorg. Med. Chem. Lett. 1998, 8, 1919-
1922.
(33) Kingston, A. E.; Ornstein, P. L.; Wright, R. A.; J ohnson, B. G.;
Mayne, N. G.; Burnett, J . P.; Belagaje, R.; Wu, S.; Schoepp, D.
D. LY341495 is a nanomolar potent and selective antagonist of
group II metabotropic glutamate receptors. Neuropharmacology
1998, 37, 1-12.
(34) J ohnson, B. G.; Wright, R. A.; Arnold, M. B.; Wheeler, W. J .;
Ornstein, P. L.; Schoepp, D. D. [3H]-LY341495 as a Novel
Antagonist Radioligand for Group II Metabotropic Glutamate
(mGlu) Receptors: Characterization of Binding to Membranes
of mGlu Receptor Subtype Expressing Cells. Neuropharmacology
1999, in press.
(35) Cheng, Y. C.; Prusoff, W. H. Relationship between the inhibition
constant (Ki) and the concentration of inhibitor which causes
fifty percent inhibition (IC50) of an enzymatic reaction. Biochem.
Pharmacol. 1973, 22, 3099-3103.
(22) Flor, P. J .; Lukic, S.; Ru¨egg, D.; Leonhardt, T.; Kno¨pfef, T.; Kuhn,
R. Molecular cloning, functional expression and pharmacological
characterization of the human metabotropic glutamate receptor
type 4. Neuropharmacology 1995, 34, 149-155.
(23) Ahmadian, H.; Nielsen, B.; Bra¨uner-Osborne, H.; J ohansen, T.
N.; Stensbøl, T. B.; Sløk, F. A.; Sekiyama, N.; Nakanishi, S.;
Krogsgaard-Larsen, P.; Madsen, U. (S)-Homo-AMPA, a specific
agonist at the mGlu6 subtype of metabotropic glutamic acid
receptors. J . Med. Chem. 1997, 40, 3700-3705.
(24) The carboxycyclopropanation of furan and thiophene with ethyl
diazoacetate has been previously reported: (a) Wenkert, E.; Guo,
M.; Lavilla, R.; Porter, B.; Ramachandran, K.; Sheu, J .-H.
Polyene Synthesis. Ready Construction of Retinol-Carotene
Fragments (()-6-(E)-LTB3 Leukotrienes and Corticrocin. J . Org.
Chem. 1990, 55, 6203-6214. (b) Gillespie, R. J .; Porter, A. E. A.
(36) Wu, S.; Wright, R. A.; Rockey, P. K.; Burgett, S. G.; Arnold, J .
S.; Rosteck, P. R., J r.; J ohnson, B. G.; Schoepp, D. D.; Belagaje,
R. Group III human metabotropic glutamate receptors 4, 7 and
8: Molecular cloning, functional expression, and comparison of
pharmacological properties in RGT cells. Mol. Brain Res. 1998,
53, 88-97.
(37) Tizzano, J . P.; Griffey, K. I.; J ohnson, J . A.; Fix, A. S.; Helton,
D. R.; Schoepp, D. D. Intracerebral 1S,3R-1-aminocyclopentane-
1,3-dicarboxylic Acid (1S,3R-ACPD) produces limbic seizures
that are not blocked by ionotropic glutamate receptor antago-
nists. Neurosci. Lett. 1993, 162, 12-16.
(38) A constrained glutamate analogue possessing a similar glutamate
conformation to that of 5, but occupying a slightly different steric
space (ABHxD-I), has been reported to display significantly lower
group II mGlu receptor agonist potency and selectivity as